| Yongkuma C Yongkuma, MD | |
|
1212 E Three Notch St, Andalusia, AL 36420-3402 | |
| (334) 222-6041 | |
| (334) 222-1595 |
| Full Name | Yongkuma C Yongkuma |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 1212 E Three Notch St, Andalusia, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417148081 | NPI | - | NPPES |
| 000109308 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 29462 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Andalusia Health | Andalusia, AL | Hospital |
| D W Mcmillan Memorial Hospital | Brewton, AL | Hospital |
| Entity Name | Vyas And Vyas Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528255601 PECOS PAC ID: 4981624962 Enrollment ID: O20051206000410 |
News Archive
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
Untreated mental health disorders can be a serious problem for women and their children during pregnancy and after giving birth, during the postpartum period.
Using executive branch powers, the Obama administration has laid out new steps to cut fraud in Medicare and Medicaid, and announced that $1 billion of federal funding will go toward innovation programs designed to boost jobs and improve patient care. The president also offered comment on the super committee's progress.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yongkuma C Yongkuma, MD 1212 E Three Notch St, Andalusia, AL 36420-3402 Ph: (334) 222-6041 | Yongkuma C Yongkuma, MD 1212 E Three Notch St, Andalusia, AL 36420-3402 Ph: (334) 222-6041 |
News Archive
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
Untreated mental health disorders can be a serious problem for women and their children during pregnancy and after giving birth, during the postpartum period.
Using executive branch powers, the Obama administration has laid out new steps to cut fraud in Medicare and Medicaid, and announced that $1 billion of federal funding will go toward innovation programs designed to boost jobs and improve patient care. The president also offered comment on the super committee's progress.
› Verified 5 days ago
Dr. Darshana Vyas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Medical Park Dr, Andalusia, AL 36420 Phone: 334-222-6041 | |
Dr. Robert Irving Garver Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 South Three Notch St, Suite B, Andalusia, AL 36420 Phone: 888-681-5864 Fax: 334-222-6633 | |
Dr. Vijay Vyas, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 125 Medical Park Dr, Andalusia, AL 36420 Phone: 334-222-6041 | |
Gregory D Price Sr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Medical Park Dr Ste 1, Andalusia, AL 36420 Phone: 334-222-4327 Fax: 334-222-4333 | |
Dr. Rex Allen Butler, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 843 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8525 Fax: 334-222-3566 |